Skip to main content

Want a detailed portfolio tracker?

Caris Life Sciences (CAI) P/E (2025 - 2026)

Caris Life Sciences (CAI) P/E from Jun 30, 2025 to Jun 3, 2026. The TTM Caris Life Sciences (CAI) P/E is 127.99. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Caris Life Sciences (CAI)

YearP/EChange
2026127.99-42.62%
2025223.08N/A

Comparison Caris Life Sciences (CAI) P/E with competitors

Caris Life Sciences (CAI) P/E is 127.99.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.00%
NBYStablecoin Development Corp0.10-99.92%
ENLVEnlivex Therapeutics Ltd0.15-99.88%
FGENFibroGen Inc0.24-99.81%
TRAWTraws Pharma Inc0.47-99.63%
FBIOFortress Biotech Inc0.71-99.45%
CHRSCoherus Biosciences Inc0.98-99.24%
ORMPOramed Pharmaceuticals Inc1.47-98.85%
AGENAgenus Inc2.05-98.40%
VIVSVivoSim Labs Inc2.54-98.02%
INVAInnoviva Inc3.19-97.51%
CRMDCorMedix Inc3.65-97.15%
ABEOAbeona Therapeutics Inc4.20-96.71%
VXRTVaxart Inc4.26-96.67%
CVACCureVac N.V.4.45-96.53%
SRPTSarepta Therapeutics Inc4.62-96.39%
GLPGGalapagos NV4.86-96.20%
RIGLRigel Pharmaceuticals4.92-96.16%
ZVRAZevra Therapeutics Inc4.97-96.11%
ABUSArbutus Biopharma Corp5.69-95.55%
CGENCompugen Ltd7.38-94.23%
AUPHAurinia Pharmaceuticals Inc9.25-92.77%
ACADAcadia Pharmaceuticals Inc9.59-92.51%
OMEROmeros Corporation9.88-92.28%
PLXProtalix BioTherapeutics Inc9.91-92.26%
SPROSpero Therapeutics Inc10.73-91.61%
ADMAAdma Biologics Inc11.33-91.15%
SVASinovac Biotech Ltd11.44-91.07%
TBPHTheravance Biopharma Inc11.78-90.80%
HRMYHarmony Biosciences Holdings Inc12.18-90.48%
TGTXTG Therapeutics Inc13.18-89.70%
INCYIncyte Corp13.38-89.54%
SABSSAB Biotherapeutics Inc14.06-89.02%
XOMAXOMA Corp14.95-88.32%
REGNRegeneron Pharmaceuticals Inc14.98-88.30%
PBYIPuma Biotechnology Inc15.05-88.24%
EXELExelixis Inc15.79-87.66%
NAGENiagen Bioscience Inc16.35-87.22%
CPRXCatalyst Pharmaceuticals Inc17.34-86.45%
MDXGMimedx Group Inc17.38-86.42%
ARGXArgen X SE23.07-81.97%
HALOHalozyme Therapeutics Inc23.20-81.87%
XOMAOXOMA Corp25.34-80.20%
VRTXVertex Pharmaceuticals Inc25.66-79.96%
XOMAPXOMA Corp25.67-79.94%
CTMXCytomX Therapeutics Inc25.70-79.92%
ASNDAscendis Pharma A/S26.35-79.41%
RPRXRoyalty Pharma plc - Class A27.50-78.52%
SLNOSoleno Therapeutics Inc29.02-77.33%
LGNDLigand Pharmaceuticals Inc - Class B30.19-76.42%
BMRNBiomarin Pharmaceutical Inc37.51-70.70%
APLSApellis Pharmaceuticals Inc39.02-69.51%
KRYSKrystal Biotech Inc39.70-68.98%
GMABGenmab40.20-68.59%
ONCBeiGene Ltd67.03-47.63%
TECHBio-Techne Corp68.59-46.41%
VCELVericel Corp80.63-37.01%
PHARPharming Group N.V.87.74-31.45%
ALNYAlnylam Pharmaceuticals Inc124.93-2.39%
TLXTelix Pharmaceuticals Ltd139.89+9.29%
CORTCorcept Therapeutics Inc158.39+23.75%